[EN] MASP-2 INHIBITORS AND METHODS OF USE<br/>[FR] INHIBITEURS DE MASP-2 ET PROCÉDÉS D'UTILISATION
申请人:OMEROS CORP
公开号:WO2021113686A1
公开(公告)日:2021-06-10
The present disclosure provides, inter alia, compounds with MASP-2 inhibitory activity, compositions of such compounds, and methods of making and using such compounds.
本公开提供了具有MASP-2抑制活性的化合物,这些化合物的组合物以及制备和使用这些化合物的方法。
[EN] LIPID A MIMICS, METHODS OF PREPARATION, AND USES THEREOF<br/>[FR] MIMÉTIQUES DE LIPIDE A, PROCÉDÉS DE PRÉPARATION, ET LEURS UTILISATIONS
申请人:IMMUNOVACCINE TECHNOLOGIES INC
公开号:WO2016109880A1
公开(公告)日:2016-07-14
The invention provides lipid A mimics in which one or both of the sugar residues of a natural lipid A disaccharide backbone has been replaced with an aromatic group. These lipid A mimics may further differ from a natural lipid A molecule with respect to other structural characteristics, such as, a different number of phosphate groups present, changes in the number, structure and location of lipid chains and/or changes in the spacing and linkage of the sugar residues (or their aromatic replacements). The lipid A mimics may be lipid A agonists and as such may be useful as immunostimulatory agents in inducing or patenting an antibody and/or cell-mediated immune response, or may be lipid A antagonists and as such may be useful in treating or preventing a lipopolysaccharide (LPS)/lipid A-mediated disease or disorder. Also provided are methods for preparing the lipid A mimics.
MITOTIC KINESIN INHIBITORS AND METHODS OF USE THEREOF
申请人:Hans Jeremy
公开号:US20130109656A1
公开(公告)日:2013-05-02
This invention relates to inhibitors of mitotic kinesins, particularly KSP, and methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing the inhibitors and pharmaceutical compositions in the treatment and prevention of various disorders.
MITOTIC KINESIN INHIBTORS AND METHODS OF USE THEREOF
申请人:Array BioPharma Inc.
公开号:US20150191490A1
公开(公告)日:2015-07-09
This invention relates to inhibitors of mitotic kinesins, particularly KSP, and methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing the inhibitors and pharmaceutical compositions in the treatment and prevention of various disorders.
A composition exhibiting second order nonlinear optical properties containing a non-centrosymmetric aromatic nonlinear optical compound possessing a delocalized resonance configuration as a guest in a host polyquinoline polymer matrix.